Matches in SemOpenAlex for { <https://semopenalex.org/work/W2971582493> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- W2971582493 endingPage "iii84" @default.
- W2971582493 startingPage "iii84" @default.
- W2971582493 abstract "Abstract BACKGROUND Brain metastases (BM) account for the majority of intracranial malignant tumours in the elderly. Almost 50% of BM originate from lung cancer, particularly non-small cell lung cancer (NSCLC). The objective of this review is to summarize the involvement of elderly patients in emerging systemic therapies especially targeted therapies for the treatment of BM from NSCLC. MATERIAL AND METHODS PubMed database was searched from 2008 to December 2018. Randomized controlled trials and systematic reviews for BM from NSCLC treated with targeted therapy were included. RESULTS A total of 85 studies were evaluated for eligibility, and 23 publications met the eligibility criteria and were screened for inclusion. Of these, only two phase-III studies met all the criteria (Sperduto 2013, Yang 2017), and three other studies of subgroup analysis of trials were focused on BM (Schuler 2016, Gadgeel 2018, Camidge 2018). In the 23 papers, eligibility criteria for age were from 18 years to 75 years old or no upper limits. Actual mean or median ages ranged 51 to 64 years. Population of patients with active BM consisted none to 100% in each study. The two phase-III studies focused on treatment of BM, median ages were 63 and 57 years. The latter reported a TKI showed significantly longer intracranial PFS and no difference in HR was found in age groups older or younger than 60 years. In the three papers of subgroup analysis, response rate of BM or intracranial distant recurrence were examined. Median ages were 51 to 62 years, ranged from 18 to 86 years. However in these analytical efforts, no results were reported about age as an outcome factor. CONCLUSION Patients with active or treated BM have become included in randomized controlled trials of systemic pharmacotherapies. Elderly patients also have become included in trials. However, outcomes focused on BM are not clearly understood especially in elderly patients. We need prospective studies and assessment of targeted therapy for elderly patients with BM for better understanding of treatment strategies and options for those patients increasing in number." @default.
- W2971582493 created "2019-09-12" @default.
- W2971582493 creator A5024806493 @default.
- W2971582493 creator A5045433611 @default.
- W2971582493 creator A5081789253 @default.
- W2971582493 date "2019-08-01" @default.
- W2971582493 modified "2023-09-23" @default.
- W2971582493 title "P14.70 Systemic therapy for brain metastases in elderly patients with lung cancer: A systematic review" @default.
- W2971582493 doi "https://doi.org/10.1093/neuonc/noz126.305" @default.
- W2971582493 hasPublicationYear "2019" @default.
- W2971582493 type Work @default.
- W2971582493 sameAs 2971582493 @default.
- W2971582493 citedByCount "0" @default.
- W2971582493 crossrefType "journal-article" @default.
- W2971582493 hasAuthorship W2971582493A5024806493 @default.
- W2971582493 hasAuthorship W2971582493A5045433611 @default.
- W2971582493 hasAuthorship W2971582493A5081789253 @default.
- W2971582493 hasBestOaLocation W29715824931 @default.
- W2971582493 hasConcept C121608353 @default.
- W2971582493 hasConcept C126322002 @default.
- W2971582493 hasConcept C143998085 @default.
- W2971582493 hasConcept C177713679 @default.
- W2971582493 hasConcept C185926286 @default.
- W2971582493 hasConcept C2776256026 @default.
- W2971582493 hasConcept C530470458 @default.
- W2971582493 hasConcept C71924100 @default.
- W2971582493 hasConceptScore W2971582493C121608353 @default.
- W2971582493 hasConceptScore W2971582493C126322002 @default.
- W2971582493 hasConceptScore W2971582493C143998085 @default.
- W2971582493 hasConceptScore W2971582493C177713679 @default.
- W2971582493 hasConceptScore W2971582493C185926286 @default.
- W2971582493 hasConceptScore W2971582493C2776256026 @default.
- W2971582493 hasConceptScore W2971582493C530470458 @default.
- W2971582493 hasConceptScore W2971582493C71924100 @default.
- W2971582493 hasIssue "Supplement_3" @default.
- W2971582493 hasLocation W29715824931 @default.
- W2971582493 hasLocation W29715824932 @default.
- W2971582493 hasOpenAccess W2971582493 @default.
- W2971582493 hasPrimaryLocation W29715824931 @default.
- W2971582493 hasRelatedWork W1576215238 @default.
- W2971582493 hasRelatedWork W2133250258 @default.
- W2971582493 hasRelatedWork W2210255672 @default.
- W2971582493 hasRelatedWork W2246446342 @default.
- W2971582493 hasRelatedWork W2316556534 @default.
- W2971582493 hasRelatedWork W2400730892 @default.
- W2971582493 hasRelatedWork W2416426706 @default.
- W2971582493 hasRelatedWork W2511733155 @default.
- W2971582493 hasRelatedWork W2557302545 @default.
- W2971582493 hasRelatedWork W2566197782 @default.
- W2971582493 hasRelatedWork W2570688920 @default.
- W2971582493 hasRelatedWork W2765823393 @default.
- W2971582493 hasRelatedWork W2984155200 @default.
- W2971582493 hasRelatedWork W2989179363 @default.
- W2971582493 hasRelatedWork W3030970257 @default.
- W2971582493 hasRelatedWork W3080602065 @default.
- W2971582493 hasRelatedWork W3168946737 @default.
- W2971582493 hasRelatedWork W324768308 @default.
- W2971582493 hasRelatedWork W617371651 @default.
- W2971582493 hasRelatedWork W2518571212 @default.
- W2971582493 hasVolume "21" @default.
- W2971582493 isParatext "false" @default.
- W2971582493 isRetracted "false" @default.
- W2971582493 magId "2971582493" @default.
- W2971582493 workType "article" @default.